Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones

被引:28
作者
Conaway, HH
Grigorie, D
Lerner, UH
机构
[1] UMEA UNIV,DEPT ORAL CELL BIOL,S-90187 UMEA,SWEDEN
[2] UNIV ARKANSAS MED SCI,DEPT PHYSIOL & BIOPHYS,LITTLE ROCK,AR 72205
关键词
D O I
10.1677/joe.0.1550513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Differential effects on in vitro bone resorption were observed when the glucocorticoids, hydrocortisone and dexamethasone, were added to neonatal mouse calvariae treated with either parathyroid hormone (PTH), 1,25(OH)(2)-vitamin D-3, all trans-retinoic acid (t-RA), or prostaglandin E-2 (PGE(2)). Bone resorption was assessed by analyzing either the release of Ca-45 from [Ca-45]CaCl2 prelabeled calvarial bones or the release of H-3 from [H-3]proline prelabeled calvariae. At PGE(2) concentrations of 3 x 10(-8) and 3 x 10(-7) mol/l, co-treatment with either 10(-6) mol/l dexamethasone or 10(-6) mol/l hydrocortisone caused additive Ca-45 release from neonatal mouse calvariae. In contrast, synergistic release from mouse calvarial bones of both Ca-45 and H-3 was found after either 10(-6) mol/l hydrocortisone or 10(-6) mol/l dexamethasone was combined with 3 x 10(-11) mol/l PTH treatment for 120 h. Dose-response studies indicated that the synergistic stimulation of Ca-45 release from neonatal mouse calvariae by glucocorticoids and PTH could be elicited at glucocorticoid concentrations of 10(-8) to 10(-6) mol/l and at PTH concentrations of 10(-11) to 10(-9) mol/l. Progesterone and RU 38486 (a derivative of 19-nortestosterone with antiglucocorticoid activity) blocked the synergism noted with glucocorticoid and PTH cotreatment, suggesting that interaction between the steroids and PTH was dependent on glucocorticoid receptor interaction. Addition of either 10(-6) mol/l hydrocortisone or 10(-6) mol/l dexamethasone to neonatal mouse calvariae treated with 1,25(OH)(2)-vitamin D-3 (10(-11) and 10(-10) mol/l) also resulted in synergistic stimulation of Ca-45 release. In contrast to these observations, the stimulatory effect of t-RA (10(-8) mol/l) on Ca-45 release from calvarial bones was abolished in the presence of 10(-6) mol/l dexamethasone. These results suggest that an important role of glucocorticoids may be to synergistically potentiate bone resorption stimulated by PTH and 1,25(OH)(2)-vitamin D-3, but indicate an opposing interaction between the glucocorticoids and bone resorptive retinoids.
引用
收藏
页码:513 / 521
页数:9
相关论文
共 38 条
[1]   GLUCOCORTICOIDS AND OSTEOPOROSIS [J].
ADLER, RA ;
ROSEN, CJ .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (03) :641-654
[2]   RETINOIDS MODULATE THE BINDING-CAPACITY OF THE GLUCOCORTICOID RECEPTOR AND ITS TRANSLOCATION FROM CYTOSOL TO NUCLEUS IN LIVER-CELLS [J].
AUDOUINCHEVALLIER, I ;
PALLET, V ;
COUSTAUT, M ;
ALFOS, S ;
HIGUERET, P ;
GARCIN, H .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 52 (04) :321-328
[3]  
BARSHAVIT Z, 1984, J CLIN INVEST, V43, P1277
[4]   ELEVATED 1,25-DIHYDROXYVITAMIN-D LEVELS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE TREATED WITH PREDNISONE [J].
BIKLE, DD ;
HALLORAN, B ;
FONG, L ;
STEINBACH, L ;
SHELLITO, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (02) :456-461
[5]   EFFECTS OF THYROCALCITONIN AND PHOSPHATE ION ON PARATHYROID-HORMONE STIMULATED RESORPTION OF BONE [J].
BRAND, JS ;
RAISZ, LG .
ENDOCRINOLOGY, 1972, 90 (02) :479-+
[7]  
CHEN TL, 1982, J BIOL CHEM, V257, P13564
[8]  
CHEN TL, 1983, J BIOL CHEM, V258, P4350
[9]  
Conaway HH, 1996, J BONE MINER RES, V11, P1419
[10]  
Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137